Safety of JAK inhibitor use in patients with rheumatoid arthritis who developed herpes zoster after receiving JAK inhibitors

被引：0
|
作者：
Wonho Choi
Soo Min Ahn
Yong-Gil Kim
Chang-Keun Lee
Bin Yoo
Seokchan Hong
机构：
[1] University of Ulsan College of Medicine,Division of Rheumatology, Department of Internal Medicine, Asan Medical Center
[2] University of Ulsan College of Medicine,Department of Rheumatology, Asan Medical Center
来源：
Clinical Rheumatology | 2022年 / 41卷
关键词：
Herpes zoster; JAK inhibitor; Recurrence; Rheumatoid arthritis; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1659 / 1663
页数：4
相关论文
共 50 条
  • [1] Safety of JAK inhibitor use in patients with rheumatoid arthritis who developed herpes zoster after receiving JAK inhibitors
    Choi, Wonho
    Ahn, Soo Min
    Kim, Yong-Gil
    Lee, Chang-Keun
    Yoo, Bin
    Hong, Seokchan
    CLINICAL RHEUMATOLOGY, 2022, 41 (06) : 1659 - 1663
  • [2] Safety of JAK Inhibitor in Patients with Rheumatoid Arthritis Who Developed Reactivation of Herpes Zoster Virus After Receiving JAK Inhibitor
    Choi, Wonho
    Ahn, Soo Min
    Kim, Yong Gil
    Lee, Chang-Keun
    Yoo, Bin
    Hong, Seokchan
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3238 - 3239
  • [3] Turning the Tide against Herpes Zoster in Rheumatoid Arthritis Patients Treated with JAK Inhibitors
    Cito, Andrea
    Fornaro, Marco
    Carenza, Angela
    Anelli, Maria Grazia
    Scioscia, Crescenzio
    Iannone, Florenzo
    Lopalco, Giuseppe
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (15)
  • [4] Exploring multidimensional factors of herpes zoster risk in rheumatoid arthritis patients undergoing JAK inhibitor treatment
    Zhou, Lianwei
    Xing, Yuhe
    Li, Wenbo
    CLINICAL RHEUMATOLOGY, 2024, 43 (09) : 3033 - 3034
  • [5] Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis
    Kang, Eun Ha
    Liao, Katherine P.
    Kim, Seoyoung C.
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (07)
  • [6] Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in patients with rheumatoid arthritis who discontinued JAK inhibitor therapy
    Andrea, Amstad
    Eleftherios, Papagiannoulis
    Almut, Scherer
    Andrea, Rubbert-Roth
    Axel, Finckh
    Ruediger, Mueller
    Jean, Dudler
    Burkhard, Moller
    Peter, Villiger M.
    Martin, Schulz M. P.
    Diego, Kyburz
    SWISS MEDICAL WEEKLY, 2022, 152 : 5S - 5S
  • [7] Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritis
    Harigai, Masayoshi
    RHEUMATOLOGY, 2019, 58 : 34 - 42
  • [8] Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis
    Eun Ha Kang
    Katherine P. Liao
    Seoyoung C. Kim
    Current Rheumatology Reports, 2018, 20
  • [9] Adherence Patterns in Rheumatoid Arthritis Patients Receiving a Janus Kinase (JAK) Inhibitor or a Tumor Necrosis Factor a Inhibitor (TNFi) After the Addition of a Black Box Warning to JAK Inhibitors
    Rutter, W. Cliff
    Patel, Kunal
    Delgado, Samantha
    Cozzi, Guy
    Avalos-Reyes, Elisea
    Cavers, Will
    Liu, Chen
    Grover, Rashmi
    Feczko, Lucia
    Johnson, Kjel
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4228 - 4229
  • [10] Herpes Zoster in Patients Receiving JAK Inhibitors For Ulcerative Colitis: Mechanism, Epidemiology, Management, and Prevention
    Colombel, Jean-Frederic
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (10) : 2173 - 2182
12345